Immunotherapeutics for head and neck squamous cell carcinoma stem cells.

Immunotherapeutics for head and neck squamous cell carcinoma stem cells.:

Related Articles

Immunotherapeutics for head and neck squamous cell carcinoma stem cells.

HNO. 2020 Jan 29;:

Authors: Qian X, Leonard F, Wenhao Y, Sudhoff H, Hoffmann TK, Ferrone S, Kaufmann AM, Albers AE

Abstract

Cancer stem cell (CSC)-related therapy resistance has become a new obstacle to the successful application of cancer treatment and head and neck squamous cell carcinoma (HNSCC) is no exception to this finding. Head and neck squamous cell carcinoma is highly immune-suppressive, and recently the immune suppression and invasion of HNSCC-CSCs have been characterized. These characteristics have received research and clinical attention because they would enable the stratification of patients into specific cancer subtypes and, consequently, the establishment of new therapeutic approaches with improved efficacy. This review discusses the feasibility of CSC-targeted strategies and their incorporation with nanotechnology to improve the efficacy of cancer immunotherapy.

PMID: 31996933 [PubMed - as supplied by publisher]